Company profile

Biotest company profile

Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and biotherapeutic drugs. Their value chain extends from pre-clinical and clinical development to worldwide marketing and distribution. Biotest manufactures immunoglobulins, clotting factors and albumins which derive from human blood plasma. Biotest also develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus which are produced by recombinant technologies. Biotest currently employs more than 2,500 people worldwide. The most important raw material for their pharmaceuticals is human blood plasma, which they process into effective and highly..... For more information, log in to dureach.com to view the full company profile.

Business identity

Phone number
+49 6103 8014406
Operating status
Active
Company type
For Profit
Employee range
01001-05000 employees
Revenue range
$500K+
Founded
1946-01-01

Headquarters

Headquarters
Dreieich, Hesse, Germany
Country code
DE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Articles
66
Exited on
2021-09-17

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.